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Original Investigation | Neurology

Association Between 5-Year Clinical Outcome in Patients
With Nonmedically Evacuated Mild Blast Traumatic Brain Injury and
Clinical Measures Collected Within 7 Days Postinjury in Combat
Christine L. Mac Donald, PhD; Jason Barber, MS; Jana Patterson; Ann M. Johnson; Sureyya Dikmen, PhD; Jesse R. Fann, MD, MPH; Nancy Temkin, PhD

Abstract

Key Points

IMPORTANCE Although previous work has examined clinical outcomes in combat-deployed
veterans, questions remain regarding how symptoms evolve or resolve following mild blast traumatic
brain injury (TBI) treated in theater and their association with long-term outcomes.

Question What clinical measures
collected acutely in combat are
associated with 5-year outcome in
patients with concussive blast injury?

OBJECTIVE To characterize 5-year outcome in patients with nonmedically evacuated blast

Findings In this longitudinal cohort

concussion compared with combat-deployed controls and understand what clinical measures

study, nonmedically evacuated blast

collected acutely in theater are associated with 5-year outcome.

concussion patients had significant and
sustained symptoms of neurobehavioral

DESIGN, SETTING, AND PARTICIPANTS A prospective, longitudinal cohort study including 45

impairment, mental health and global

service members with mild blast TBI within 7 days of injury (mean 4 days) and 45 combat deployed

disability, whereas cognitive changes

nonconcussed controls was carried out. Enrollment occurred in Afghanistan at the point of injury

were unremarkable compared with

with evaluation of 5-year outcome in the United States. The enrollment occurred from March to

combat-deployed nonconcussed

September 2012 with 5-year follow up completed from April 2017 to May 2018. Data analysis was

controls. Assessments collected in

completed from June to July 2018.

theater were associated with multiple
domains of outcome.

EXPOSURES Concussive blast TBI. All patients were treated in theater, and none required medical
evacuation.

Meaning Nonmedically evacuated
patients with concussive blast injury,
considered the mildest of the mild

MAIN OUTCOMES AND MEASURES Clinical measures collected in theater included measures for
concussion symptoms, posttraumatic stress disorder (PTSD) symptoms, depression symptoms,
balance performance, combat exposure intensity, cognitive performance, and demographics. Five-

combat casualties fared poorly 5 years
later compared with combat-deployed
controls.

year outcome evaluation included measures for global disability, neurobehavioral impairment, PTSD
symptoms, depression symptoms, and 10 domains of cognitive function. Forward selection
multivariate regression was used to determine predictors of 5-year outcome for global disability,
neurobehavior impairment, PTSD, and cognitive function.

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

RESULTS Nonmedically evacuated patients with concussive blast injury (n = 45; 44 men, mean [SD]
age, 31 [5] years) fared poorly at 5-year follow-up compared with combat-deployed controls (n = 45;
35 men; mean [SD] age, 34 [7] years) on global disability, neurobehavioral impairment, and
psychiatric symptoms, whereas cognitive changes were unremarkable. Acute predictors of 5-year
outcome consistently identified TBI diagnosis with contribution from acute concussion and mental
health symptoms and select measures of cognitive performance depending on the model for 5-year
global disability (area under the curve following bootstrap validation [AUCBV] = 0.79),
neurobehavioral impairment (correlation following bootstrap validation [RBV] = 0.60), PTSD severity
(RBV = 0.36), or cognitive performance (RBV = 0.34).
(continued)
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Abstract (continued)

CONCLUSIONS AND RELEVANCE Service members with concussive blast injuries fared poorly at
5-year outcome. The results support a more focused acute screening of mental health following TBI
diagnosis as strong indicators of poor long-term outcome. This extends prior work examining
outcome in patients with concussive blast injury to the larger nonmedically evacuated population.
JAMA Network Open. 2019;2(1):e186676. doi:10.1001/jamanetworkopen.2018.6676

Introduction
The long-term clinical impact of war-time mild blast-related traumatic brain injury (TBI) remains
incompletely described.1,2 Previous studies have been based largely on self-report and screening
tools3-6 to define TBI, rather than direct clinical assessments in cohorts identified at the time of injury
and prospectively studied. Although much effort has been expended to better understand this type
of concussive TBI, many studies in active-duty US military and veterans have been restricted to crosssectional evaluations,4,7-15 often involving retrospective record review7-9,16 or
self-report,4,6,10-12,14,16-19 and considering only chronic phases of injury.13,16,18,20,21
Few longitudinal studies have been completed in this population, largely restricted to the first
year after exposure19,22-26 or by serial evaluation only in the chronic stage.27,28 One prior study
compared predeployment, postdeployment, and more than 5-year follow-up; however, the study did
not restrict inclusion to just mild TBI and did not discriminate between medically evacuated vs
nonmedically evacuated cases.29 The findings and prior body of literature motivate further research
to better characterize risk factors that can be associated with long-term outcomes after specifically
mild TBI exposures in combat. Questions remain regarding how symptoms evolve or resolve
following mild blast-related TBI treated in theater and how they are associated with the service
member’s long-term trajectory.
Our own work has shown an evolution, not resolution, of symptoms by 5-year follow-up in
patients with blast-related mild TBI30,31 who were medically evacuated from the combat theater.
Less is known about the long-term outcome trajectory in the larger population of nonmedically
evacuated service members who sustain blast-related mild TBI, mild enough to remain in theater for
treatment and return to their unit. Through collaborative efforts at Kandahar Airfield, Camp
Leatherneck, and academic universities in the United States, we have been provided the unique
opportunity to follow the very same patients from the point of injury in theater32 to both 1-year,22
and now 5-year outcome. The objective of the current study was to characterize 5-year outcome in
patients with nonmedically evacuated mild blast TBI and to understand what clinical measures
collected within the first week of injury in combat best predicted clinical outcome 5 years later
because this has important implications for acute care considerations of combat casualties who have
sustained these concussion exposures.

Methods
Participants were initially enrolled at Kandahar Air Field and Camp Leatherneck in Afghanistan
between March and September 2012 through a prospective, observational, research study.22,32 As
part of ongoing efforts, these very same participants have been followed to 1-year,22 and now to
5-year follow-up (completed April 2017 to May 2018). In all, 212 participants were originally enrolled
in combat (106 controls, 106 concussive blast).32 Owing to funding limitations, only 100 were invited
for 5-year follow-up as was done for 1-year follow-up,22 and priority was placed on bringing back
those who had completed prior follow-up evaluation. Two groups were enrolled, blast-related
combat concussion and combat-deployed controls. Inclusion criteria for the concussion group were
(1) clinical diagnosis of mild uncomplicated or concussive TBI from a blast exposure within the past 7
days made by a trained, board-certified neurologist or neurosurgeon based on the criteria from the
JAMA Network Open. 2019;2(1):e186676. doi:10.1001/jamanetworkopen.2018.6676 (Reprinted)
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American Congress of Rehabilitation Medicine 1993 (loss of consciousness 0-30 minutes,
posttraumatic amnesia <24 hours, Glasgow coma scale 13-15, absent radiological findings), (2) injury
from blast exposure within 7 days of enrollment, (3) US military, (4) ability to provide informed
consent in person, (5) no contraindications to magnetic resonance imaging (MRI) such as retained
metallic fragments, (6) no prior history of moderate to severe TBI based on Department of Defense
criteria, (7) no prior history of mental health or psychiatric diagnosis, (8) and agreement to
communicate by telephone or email and then travel to University of Washington for in-person
follow-up. Inclusion criteria for the combat-deployed control group were the same except for a
negative assessment for TBI and no history of blast exposure. The research protocol was approved
by the institutional review board at the University of Washington and the US Army Medical Research
and Material Command institutional review board. This study was conducted in accordance with the
approved protocol. Written informed consent was obtained from all participants in person at each
time point; no surrogate consent was allowed. See eMethods in the Supplement for further details.
For the concussion group, no intracranial abnormalities were detected on noncontrast head
computed tomographic (CT) results at the time of enrollment.32 All concussion patients met the
Department of Defense criteria for uncomplicated, mild TBI. All clinical histories were verified by
study personnel taking additional clinical history and reviewing medical records. Mean (SD) time
from injury to enrollment was 3.76 (1.74) days with a total range of 0 to 7 days. At the 5-year
follow-up, further history was taken to assess whether there had been any additional injuries or
exposures between the time of enrollment and the follow-up evaluation years later that could affect
long-term outcome. Race/ethnicity was collected as a demographic variable and was identified by
the participant at follow-up.

Acute Evaluation Assessments
At the time of enrollment in Afghanistan, the following assessments were completed by both
concussion and combat-deployed control participants: Rivermead Post-Concussion Symptom
Questionnaire (RPCSQ),33 Posttraumatic Stress Disorder Check List-Military (PCL-M),34 Beck
Depression Inventory (BDI),35 Combat Exposure Scale,36 Balance Error Scoring System (BESS),37
Automated Neurocognitive Assessment Metrics–Traumatic Brain Injury Military Version 4 (ANAM),38
and Test of Memory Malingering.39 Total examination time took approximately 1 hour and 15 minutes.

5-Year Follow-up Evaluation Assessments
In-person clinical evaluations at University of Washington included a structured neurobehavioral
interview, neuropsychological battery consisting of 10 cognitive tests, and structured psychiatric
evaluation with additional self-administered questionnaires. Evaluations lasted approximately 5
hours: 1 hour of standardized neurological assessment, 2 hours for cognitive testing, and 2 hours for
psychiatric evaluation. Participants took all medications as prescribed by their clinicians. All tests
were performed between 8 AM and 5 PM in private, quiet, well-lighted rooms. All examiners were
blinded to prior diagnoses and clinical histories, although during some of the interviews it may have
become clear which group participants were in given endorsements of prior events. All examiners
were psychometrists who underwent standardized training for administration.
Overall global disability was assessed using the Glasgow Outcome Scale Extended (GOS-E).40,41
Participants were instructed to consider deployment as the reference point for this interview. Poor
outcome was defined as GOS-E 6 or less indicating moderate to severe disability. Additional
information on the GOS-E and further neuropsychological battery details can be found in the
Supplement.
The neurological assessment included a structured interview designed for patients with TBI
(Neurobehavioral Rating Scale-Revised [NRS-R]42) scored with the 5 subdomains,43 2 headache
interviews capturing frequency and intensity (Migraine Disability Assessment44 and Headache
Impact Test45), the Neurological Outcome Scale for TBI46-48 designed to assess focal neurological
deficits associated with TBI, and a TBI history intake interview modified from the Brain Injury
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Screening Questionnaire,49 to confirm life history of head injury exposure and identify new head
injuries sustained since last evaluation. Participants then completed the Quality of Life after Brain
Injury50,51 questionnaire capturing current life satisfaction.
The psychiatric evaluation included structured interviews and self-administered questionnaires.
The Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual of Mental Disorders
(Fourth Edition) (CAPS)52 and Montgomery-Asberg Depression Rating Scale53 for depression were
administered as structured interviews before the participant completed the: PCL-M,34 BDI,35 Brief
Symptom Inventory-Anxiety module,54 Insomnia Severity Index,55 and Michigan Alcohol Screening
Test.56 The CAPS was scored using the rules from Blake et al.57

Statistical Analysis
Data analysis was completed June to July 2018. Differences in patient characteristics between the
mild blast TBI and combat-deployed control groups were assessed statistically using Mann-Whitney
and Fisher exact tests as appropriate. Because many of the outcome measures had highly skewed
distributions, differences in 5-year outcome measures were assessed using rank-regression
modeling58 (ie, linear regression on the ranks of the measures) that adjusted for age, education, sex,
rank, branch of service, and subsequent concussion exposure with the resulting probability values
corrected for multiple comparisons59 within each outcome domain per Benjamini-Hochberg60
(2-sided P values <.05 were considered significant).
Univariate and multivariate predictive models in 4 domains of 5-year outcome were
constructed from a predetermined set of measures collected acutely in combat using logistic
regression for global disability (dichotomized GOS-E) and linear regression for neurobehavioral
impairment (NRS-R), PTSD severity (CAPS), and a cumulative measure of Cognitive Performance.
Overall cognitive function for each participant was defined by aggregating the 19 neuropsychological
measures into a single equally weighted rank-based composite metric.61 This cognitive mean sample
percentile was calculated by converting each score to a within-measure percentile (ranging from 0
to 100) and averaging all such percentile values within each participant. Each percentile was
calculated by dividing each score's rank by the number of scores in the combined samples and
multiplying by 100, after first ensuring that all measures had been transformed as necessary such
that a low score corresponded to a good outcome.
A forward-stepwise selection algorithm (P < .05 to enter, P > .10 to exit) was used to establish a
model for each outcome. Predictive accuracy of the logistic regression models was characterized by
analyzing the receiver operating characteristic (ROC) curve and for the 3 linear regression models it
was characterized by the correlation between the predicted and actual scores. In addition to the
in-sample performance, bootstrap validation was used to provide a more generalizable estimate of
model performance.62 Modeling results are reported following bootstrap validation and indicated
with subscript “BV” to distinguish from initial regression results. Prediction of poor outcome was also
explored if only a single acute clinical assessment could be used and assessed using ROC curve
analysis, with the diagnostic threshold set at the value where the sum of the sensitivity and
specificity is maximized. Five-year outcome in the global disability domain was considered poor if
GOS-E was 6 or less, in the neurobehavioral domain if NRS-R was 10 or greater, and in the PTSD
domain if CAPS was 65 or above. The ROC curves included both concussive blast and combatdeployed controls. When looking at prediction of 2 or more domains of poor outcome, those with
poor outcome in 1 domain were excluded from the analysis.

Results
In total, 90 of 100 invited service members completed both 0-to-7 day and 5-year evaluation: 45
concussive blast TBI and 45 combat-deployed controls (Table). Ten service members invited did not
complete follow-up owing to continued deployment and related service obligations. Comparison by
group of those who completed 5-year follow-up vs those who did not identified no significant
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differences in age, sex, branch of service, military rank, or number of deployments for the concussive
blast group, whereas age and military rank slightly differed in the controls who completed follow-up
(eTable 1 in the Supplement). Given the demographic differences between groups, all comparisons of
clinical measures were adjusted for age, education, sex, rank, branch of service, in addition to
subsequent concussion exposures followed by correction for multiple comparisons with final
adjusted and corrected P values reported.
Clinical evaluation at 5-year follow-up of service members with nonmedically evacuated
concussive blast injury identified considerably worse outcomes on many measures compared with
combat-deployed controls (Figure 1) (eTable 2 in the Supplement). A significantly greater number of
patients with concussive blast injury presented with more severe levels of global disability (Figure 1A)
(mean [SD] CTL, 7.4 [0.8]; TBI, 5.8 [1.1]; P < .001) and poor quality of life (Figure 1B) (mean [SD] CTL,
24.1 [4.8]; TBI, 18.9 [4.4]; P = .001). Overall neurobehavioral impairment (Figure 1C) (mean [SD] CTL,
5.6 [5.2]; TBI, 14.8 [6.8]; P < .001) was significantly elevated in patients with concussive blast injury.
The frequency of focal neurological deficits was also significantly elevated in patients with concussive
blast injury with the most common deficit being unilateral or bilateral hearing loss, followed by
olfactory dysfunction and partial sensory loss in a lower extremity (Figure 1D) (mean [SD] CTL, 0.53
[0.76]; TBI, 2.76 [1.76]; P < .001). Posttraumatic headache frequency and impairment was also
significantly worse in nonmedically evacuated patients with concussive blast injury (Figure 1E) (mean
[SD] CTL, 3.1 [6.1]; TBI, 14.4 [16.6]; P = .004) (Figure 1F) (mean [SD] CTL, 49.0 [12.5]; TBI, 59.8 [11.3];
P = .01). Assessment for additional exposures that may have occurred between the time of
enrollment to 5-year follow-up did not identify any additional TBI diagnoses; however, 18 patients
with concussive blast injury and 5 combat-deployed controls reported events that would be
suggestive of additional concussion although medical attention was not sought. Events were
primarily fights or low speed motor vehicle/motorcycle/bicycle crashes for concussive-blast and
ground level falls for both groups.
In contrast, of the 10 neuropsychological assessments administered, only the 25-foot walk was
significantly different between groups (eTable 4 in the Supplement). Patients with concussive blast

Table. Participant Characteristics at 5-Year Follow-up
Characteristic

Combat Controls
(n = 45)

Concussive Blast TBI
(n = 45)

P Valuea

Age, mean (SD), y

34.4 (6.7)

30.6 (5.3)

.004

Education, mean (SD), y

16.6 (3.4)

13.6 (1.7)

<.001

Male

33 (73)

44 (98)

Female

12 (27)

1 (2)

Sex, No. (%)

Race/ethnicity, No. (%)

.002

b

White

35 (78)

32 (71)

Black

3 (7)

2 (4)

Hispanic/Latino

7 (16)

10 (22)

Asian

0 (0)

1 (2)

.63

Branch of service, No. (%)c
US Army

13 (29)

39 (87)

US Air Force

5 (11)

0 (0)

US Marine Corps

5 (11)

5 (11)

US Navy

22 (49)

1 (2)

Enlisted

29 (64)

43 (96)

Officer

16 (36)

2 (4)

No. of deployments, mean (SD)

1.5 (0.9)

1.8 (1.2)

Service separation, No. (%)

16 (36)

27 (60)

<.001

Military rank, No. (%)

Abbreviation: TBI, traumatic brain injury.
a

Statistical significance by Mann-Whitney or Fisher
exact test as appropriate.

.22

b

Race/ethnicity computed as white vs other.

.03

c

Branch of service computed as Army vs other.

<.001
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Figure 1. Five-Year Global Outcome, Quality of Life, and Neurobehavioral Impairment in Nonmedically Evacuated Blast Concussion
and Combat-Deployed Controls (CTL)a
A Overall global disability

B

7

Global Outcome, GOS-E

Overall life satisfaction
35

Quality of Life Satisfaction QOLIBRI

8

6

5

4

3

30
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5

P <.001

P =.001

2

0

Combat-Deployed CTL

10
P <.001

30

20
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0

P <.001
8

6

4

2

0
Combat-Deployed CTL

Concussive Blast TBI
F

Migraine disability
100

Concussive Blast TBI

Headache impact
100

P =.004

P =.01

80

Headache Impact Test (HIT-6)

Migraine Disability Scale (MIDAS)

Concussive Blast TBI

D Focal neurologic deficits

Overall neurobehavioral symptom severity
40

Combat-Deployed CTL
E

Combat-Deployed CTL

Neurological Deficits NOS-TBI Total Score

Neurobehavioral Symptoms NRS-Revised Total

C

Concussive Blast TBI

60

40

20

75

50

0
25

Combat-Deployed CTL

Combat-Deployed CTL

Concussive Blast TBI

A, Overall global disability assessed by the Glasgow Outcome Scale Extended (GOS-E, 7
or 8 categorized as good outcome and GOS-E 6 or below categorized as poor outcome).
B, Overall life satisfaction assessed by the Quality of Life After Traumatic Brain Injury
(QOLIBRI; max, 30). C, Overall neurobehavioral symptom severity assessed by the
Neurobehavioral Rating Scale Revised (NRS-R; max, 87). D, Focal neurological deficits
assessed by the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI; max,
58). Headache impairment assessed by E, the Migraine Disability Assessment (MIDAS;
max, 270) and F, the Headache Impact Test (HIT-6; max, 78; min, 36). Each symbol

Concussive Blast TBI

represents an individual participant, horizontal lines indicate mean (SD) for each graph
with corresponding values reported for each outcome in the legend. Lower values on
panels A and B indicate worse outcome. Higher values on panels C through F indicate
worse outcome. Complete summary statistics including measures of uncertainty are
reported in eTable 2 in the Supplement.
a

All P values adjusted.
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injury performed equivalently on all of the other cognitive test measures compared with combatdeployed controls.
Examination on a variety of psychiatric measures did reveal significant long-term
symptomatology in nonmedically evacuated patients with concussive blast injury related to the blast
exposure compared with combat-deployed controls (Figure 2) (eTable 3 in the Supplement). There
was significant PTSD symptom severity identified by both clinical interview (CAPS) and selfadministered questionnaire (PCL-M) (Figure 2A) ( mean [SD] CTL, 26.8 [21.7]; TBI, 55.0 [29.1];
P = .004) (Figure 2B) (mean [SD] CTL, 27.4 [11.8]; TBI, 44.7 [16.6]; P < .001). Depressive symptoms
were also significantly elevated on the clinical interview (Montgomery-Asberg Depression Rating
Scale) and questionnaire (BDI) but to a lesser extent than PTSD symptoms (Figure 2C) (mean [SD]
CTL, 9.0 [8.5]; TBI, 16.7 [10.6]; P = .05) (Figure 2D) (mean [SD] CTL, 6.1 [7.7]; TBI, 13.4 [9.8]; P = .01).
Self-endorsed anxiety symptoms (Brief Symptom Inventory-Anxiety Module) and sleep impairment
were significantly worse, whereas there was no difference in alcohol misuse between the 2 groups
(Figure 2E) (mean [SD] CTL, 3.0 [3.5]; TBI, 7.2 [5.4]; P = .007) (Figure 2F) (mean [SD] CTL, 7.4 [6.0];
TBI, 12.7 [7.2]; P = .01) (Figure 2G) (mean [SD] CTL, 1.7 [2.6]; TBI, 3.1 [3.6]; P = .49). Importantly, 35
patients (78%) with concussive blast injury and 25 combat-deployed controls (56%) reported
seeking mental health services but only 13 patients (28%) with concussive blast injury and 18
combat-deployed controls (40%) reported sustained symptom resolution.
Owing to the number of nonmedically evacuated patients with concussive blast injury with poor
5-year outcomes, we investigated if any of the acutely collected measures could predict these
outcomes. Four primary outcome domains were examined using univariate and then forwardstepwise selection multivariate modeling for global disability, neurobehavioral impairment, PTSD
symptom severity, and overall cognitive function (Figure 3) (eTables 5-8 in the Supplement).

Figure 2. Five-Year Psychiatric Symptom Severity in Nonmedically Evacuated Blast Concussion and Combat-Deployed Controls (CTL)a
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assessed by the clinician-administered PTSD scale for DSM IV (CAPS; max, 136), and B,
the self-administered PTSD checklist military version (PCL-M; max, 85; Min, 17). C,
Depression severity assessed by the Montgomery-Asberg depression rating scale
(MADRS; max, 60), and D, the self-administered Beck Depression Inventory (BDI; max,
63). E, Anxiety symptom severity assessed by the Brief Symptom Inventory Anxiety
module (BSI-A; max, 24). F, Severity of poor sleep assessed by the Insomnia Severity
Index (ISI; max, 28). G, Alcohol misuse assessed by the Michigan Alcohol Screening Test
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Blast TBI
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(MAST; max, 22). Dotted lines indicate the threshold for moderate to severe
symptomatology for each evaluation. Each symbol represents an individual participant,
horizontal lines indicate mean (SD) for each graph with corresponding values reported
for each outcome in the legend. Higher values on each measure indicate worse outcome.
Complete summary statistics including measures of uncertainty are reported in eTable 3
in the Supplement.
a

All P values adjusted.
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Traumatic brain injury diagnosis (odds ratio [OR], 7.86; P = .001) and concussion symptoms (RPCSQ;
OR, 1.06; P = .008) collected acutely in theater best predicted 5-year global disability (AUCBV = 0.79
indicating very strong predictive strength) (Figure 3A) (eTable 5 in the Supplement). Traumatic brain
injury diagnosis (B = 7.01, P < .001), being enlisted (B = 4.06, P = .004), depression symptoms (BDI,
B = 0.25, P = .006), and information processing speed (ANAM-PRT, B = 0.10, P = .02), and visual
spatial memory (ANAM-MTS, B = −0.19, P = .001) collected acutely in theater best predicted 5-year
neurobehavior impairment (RBV = 0.60 indicating strong predictive strength) (Figure 3B) (eTable 6 in
the Supplement). Traumatic brain injury diagnosis (B = 17.59, P = .006) and concussion symptoms
(RPCSQ, B = 0.72, P = .004) collected acutely best predicted 5-year PTSD severity (RBV = 0.36
indicating moderate predictive strength) (Figure 3C) (eTable 7 in the Supplement). Traumatic brain
injury diagnosis (B = 5.35, P = .007), working memory (ANAM-MTP, B = −0.45, P = .001), and
balance performance (BESS, B = −0.27, P = .02) best predicted 5-year cognitive function (RBV = 0.34
indicating moderate prediction strength) (Figure 3D) (eTable 8 in the Supplement).
Given the austere nature of the acute critical care environment in combat, we next asked the
question, if only a single evaluation tool could be used following concussion diagnosis, what measure
would best predict these domains of 5-year outcome. Acute collection of PTSD symptoms (PCL-M)
provided the strongest predictive ability for the 3 domains where patients with concussive blast
injury had worse impairment (global disability, AUC = 0.68; neurobehavioral impairment, R = 0.68;
PTSD symptoms, R = 0.58; eTable 9A-C in the Supplement). Investigation of a PCL-M threshold for
this predictive model identified a score of 27 as the optimal cut point in predicting 1 poor outcome

Figure 3. Acute Predictors of 5-Year Outcome for Global Disability, Neurobehavioral Impairment,
Posttraumatic Stress Disorder (PTSD) Symptom Severity, and Cognitive Performance
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bootstrap validation; BDI, Beck Depression Inventory;
CAPS, Counseling and Psychological Services PTSD
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RBV, correlation following bootstrap validation. A,
Logistic regression acute predictors of 5-year global
disability (AUCBV = 0.79; model parameters: TBI
diagnosis, OR = 7.86; P = .001; Concussion Symptoms
[Rivermead Post-Concussion Symptom Questionnaire;
RPCSQ], OR = 1.06; P = .008). B, Linear regression
acute predictors of 5-year neurobehavioral impairment
(RBV = 0.60; model parameters: TBI diagnosis,
B = 7.01; P < .001; enlisted status, B = −4.60; P = .004;
depression symptoms [BDI], B = 0.25; P = .006;
processing speed [Automated Neuropsychological
Assessment Metrics; ANAM-PRT], B = 0.10; P = .02;
visuospatial memory [Automated Neuropsychological
Assessment Metrics Matching to Sample; ANAMMTS], B = −0.19; P = .001). C, Linear regression acute
predictors of 5-year PTSD symptom severity
(RBV = 0.36; model parameters: TBI diagnosis,
B = 17.59; P = .006; concussion symptoms [RPCSQ],
B = 0.72; P = .005). D, Linear regression acute
predictors of 5-year cognitive performance
(RBV = 0.34; model parameters: TBI diagnosis,
B = 5.35; P = .007; working memory [ANAM-MTP],
B = −0.45; P = .001; balance performance [Balance
Error Scoring System], B = −0.27; P = .02). See
eTables 5 to 8 in the Supplement for complete details
by parameter for all univariate and multivariate models
including measures of uncertainty. Dotted line panel
A represents unity line and graph lines in panels B to D
represent regression line for each model.
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(AUC = 0.74) (Figure 4A) or more than 1 poor outcome (AUC = 0.77) (Figure 4B) indicating fair
predictive strength. Examination of the PCL-M scores in the very same participants for each group
collected acutely in combat and 5 years later revealed an overall average increase of 30% in combatdeployed controls and 54% in nonmedically evacuated patients with concussive blast injury with
most patients with concussive blast injury noting increased symptom burden (Figure 4C). Percent
change was derived by taking the difference between the 2 scores and dividing by the initial score.

Discussion
At 5-year follow-up, service members with nonmedically evacuated concussive blast injury fared
significantly more poorly than combat-deployed controls on measures of global disability,
neurobehavioral impairment, and psychiatric symptom severity whereas cognitive test performance
was similar. Predictors of overall 5-year clinical outcome across 4 different domains primarily
encompassed TBI diagnosis and acute symptoms of mental health and concussion, not acute
cognitive performance, age, sex, number of prior deployments, or number of subsequent
concussions. When considering only a single assessment tool, the PCL-M for PTSD symptoms
collected acutely in theater best predicted domains of outcome in combination with concussion
diagnosis at a cut point of 27 that is lower than the threshold typically used to indicate clinical
significance of 35.34 Both combat-deployed controls and, to a greater extent, nonmedically
evacuated patients with concussive blast injury had a substantial increase in PTSD symptom severity
over the 5-year period suggesting an evolution, not resolution, of mental health burden.

Figure 4. Acute PCL-M Score Threshold for Prediction of 5-Year Multidomain Poor Outcome
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If only a single evaluation tool could be used in combat,
the Posttraumatic Stress Disorder (PTSD) Checklist
Military Version (PCL-M) was found to have the best
predictive ability to inform poor global disability,
neurobehavioral impairment, and PTSD outcome. A
threshold of 27 provided the best cut point regardless
of whether the logistic regression model sought to
identify only A, 1 domain of poor outcome (area under
the curve [AUC] = 0.74) or B, multiple domains
(AUC = 0.77), with both indicating fair predictive
strength. C. Self-administered PTSD Checklist Military
Version was completed at 0 to 7 days postinjury in
combat and at 5-year outcome for direct comparison
over time (PCL-M; max, 85). Line plots indicate change
in score for each concussive blast patient and
combat-deployed control participant. The brown
dashed line indicates the current clinical threshold
whereas the solid brown line indicates the threshold
identified by the current prediction modeling. See
eTable 9 in the Supplement for complete details of
model optimization parameters for this multidomain
outcome prediction including measures of uncertainty.

January 4, 2019

9/14

JAMA Network Open | Neurology

Association of Clinical Measures With Outcomes Following Combat Concussion

These results are comparable to our previous 5-year findings in patients with medically
evacuated concussive blast injury31 suggesting a more universal effect of these concussive blast
exposures irrespective of evacuation status. Like the medically evacuated cohort, this group of
service members with nonmedically evacuated concussion was found to have a much greater level
of global disability than previously reported in prospective studies of comparable civilian patients
with mild TBI, even those with multisystem trauma.63,64 This has important implications for the
translatability of these combined concussive blast findings because there are far greater numbers of
service members who sustain concussion exposures in combat that are not medically evacuated.
This has been a limitation of our prior work and here we provide prospective, longitudinal evidence
for the progression in this nonmedically evacuated blast concussion population. Furthermore, the
disproportionate number of patients with concussive blast injury with subsequent exposures is in
line with prior work reporting that brain injury is in fact a risk factor for further TBI.65,66
Strengths of this study include the prospective, observational, longitudinal study design,
evaluation in multiple domains of function at both time points, enrollment of a combat-deployed
control group for comparison with the patients with concussive blast injury, concussion diagnosis
made by trained clinicians in combat not based on self-report recollection, collection of medical
history accounting for subsequent exposures that may have occurred between points of evaluation,
and clinical evaluations made by blinded examiners.

Limitations
Limitations of the study include the modest sample size, lack of demographic matching,
heterogeneous treatment centers in which these patients have sought care in the United States, and
unmeasured covariates that may influence these findings such as preinjury characteristics including
military operation specialty, or postinjury behavioral health referrals, use of sick leave, or unmeasured
alcohol use not identified on the alcohol screening test completed as part of the study. In addition,
because of the sample size, it is possible that type II error may have contributed to the
neuropsychological results in which few differences between groups were observed. Furthermore,
the study was designed to explore predictors of long-term outcome without necessarily causal
relation, so the predictors identified should not be assumed to be causally related to the concussion
exposure. It should also be noted that while the predictive models were assessed for model
performance by bootstrap validation, we cannot rule out the possibility of unappreciated overfitting
and therefore replication in an independent cohort should be completed before the models are
considered fully validated.

Conclusions
The results support a more focused and efficient acute screening of mental health in theater
following TBI diagnosis as strong indicators of poor long-term outcome. The PCL-M was found to be
the most informative measure in predicting long-term functional outcome following blast-related
mild TBI and can be completed within 1 to 2 minutes, supporting its utility in an acute triage
environment. Future studies should examine whether early intervention informed by this acute
assessment may prevent some of the adverse long-term outcomes associated with blast-related
mild TBI.
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